Stockreport

Kiromic BioPharma Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Corporate Highlights

Kiromic BioPharma, Inc.  (KRBP) 
PDF Highlights Include Company’s Progress in the Following Areas:Advances in the Research, Development, and Manufacturing Processes of the ALEXIS Gamma Delta T cell Platform [Read more]